EIKO LIFESCIENCES Limited announced that the Board of Directors in their meeting held on January 25, 2024 has considered and approved the below transaction: Company to enter into definitive business agreement with Vivacious Pharmatex Private Limited for Company's Growth and strategic positioning. Details as required under listing regulations and SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/CIR/2023.

Scope of business operation of agreement: Company and VPPL will support each other in development and marketing of products. Significant terms and conditions of agreement in brief: Strategic expansion for Eiko Lifesciences Limited into the "Oleochemicals and Allied Business" segment, a domain integral to products in personal care, pharmaceuticals, agrochemicals, paints, coatings, fragrance, polymer, and petrochemicals. Rationale and benefit expected By Entering into this agreement, Company will be preferred business partner for VPPL in terms of sourcing and supplying key raw materials.

Further VPPL, will provide full co-operation in developing new products, commercialization, and marketing at manufacturing facilities. Further, Company stands to gain from the vast knowledge, expertise, and research and development skills of the new management at VPPL. This collaboration is poised to be synergistic, ensuring innovation, growth, and success for both ELL and VPPL.